Skip to main content
TipRanks
Go Ultimate75% OFF

Samjin Pharmaceutical Co., Ltd. (005500) Stock Statistics & Valuation Metrics

Total Valuation

Samjin Pharmaceutical Co., Ltd. has a market cap or net worth of KRW 236.21B. The enterprise value is KRW 347.35B.

Market Cap
KRW 236.21B
Enterprise Value
KRW 347.35B

Share Statistics

Samjin Pharmaceutical Co., Ltd. has 13,320,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
13,320,000
Owned by Insiders
―
Owned by Institutions
0.89%

Financial Efficiency

Samjin Pharmaceutical Co., Ltd.’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 5.73%.

Return on Equity (ROE)
0.08
Return on Assets (ROA)
0.05
Return on Invested Capital (ROIC)
5.73%
Return on Capital Employed (ROCE)
0.08
Revenue Per Employee
377.45M
Profits Per Employee
29.51M
Employee Count
819
Asset Turnover
0.66
Inventory Turnover
1.41

Valuation Ratios

The current PE Ratio of Samjin Pharmaceutical Co., Ltd. is 9.06. Samjin Pharmaceutical Co., Ltd.’s PEG ratio is 0.54.

PE Ratio
9.06
PS Ratio
0.69
PB Ratio
0.72
Price to FCF
8.27
Price to Operating Cash Flow
6.34
PEG Ratio
0.54

Income Statement

In the last 12 months, Samjin Pharmaceutical Co., Ltd. had revenue of 309.13B and earned 24.17B in profits. Earnings per share was 1962.68.

Revenue
309.13B
Gross Profit
153.03B
Operating Income
24.68B
Pretax Income
22.10B
Net Income
24.17B
EBITDA
44.50B
Earnings Per Share (EPS)
1962.68

Cash Flow

In the last 12 months, operating cash flow was 33.83B and capital expenditures -7.90B, giving a free cash flow of 25.92B billion.

Operating Cash Flow
33.83B
Free Cash Flow
25.92B
Free Cash Flow per Share
2048.01

Dividends & Yields

Samjin Pharmaceutical Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of 3.97%

Dividend Per Share
―
Dividend Yield
3.97%
Payout Ratio
N/A
Free Cash Flow Yield
12.09%
Earnings Yield
10.85%

Stock Price Statistics

Beta
0.05
52-Week Price Change
-15.51%
50-Day Moving Average
19237.80
200-Day Moving Average
18892.30
Relative Strength Index (RSI)
57.32
Average Volume (3m)
41.43K

Important Dates

Samjin Pharmaceutical Co., Ltd. upcoming earnings date is Mar 18, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 16, 2026
Next Earnings Date
Mar 18, 2027
Ex-Dividend Date
―

Financial Position

Samjin Pharmaceutical Co., Ltd. as a current ratio of 1.30, with Debt / Equity ratio of 46.80%

Current Ratio
1.30
Quick Ratio
0.55
Debt to Market Cap
0.56
Net Debt to EBITDA
2.78
Interest Coverage Ratio
4.99

Taxes

In the past 12 months, Samjin Pharmaceutical Co., Ltd. has paid -2.07B in taxes.

Income Tax
-2.07B
Effective Tax Rate
-0.09

Enterprise Valuation

Samjin Pharmaceutical Co., Ltd. EV to EBITDA ratio is 17.31, with an EV/FCF ratio of 12.79.

EV to Sales
1.06
EV to EBITDA
17.31
EV to Free Cash Flow
12.79
EV to Operating Cash Flow
9.80

Balance Sheet

Samjin Pharmaceutical Co., Ltd. has KRW 20.88B in cash and marketable securities with KRW 129.88B in debt, giving a net cash position of -KRW 109.01B billion.

Cash & Marketable Securities
KRW 20.88B
Total Debt
KRW 129.88B
Net Cash
-KRW 109.01B
Net Cash Per Share
-KRW 8,183.73
Tangible Book Value Per Share
KRW 21.99K

Margins

Gross margin is 45.63%, with operating margin of 6.74%, and net profit margin of 7.47%.

Gross Margin
45.63%
Operating Margin
6.74%
Pretax Margin
7.62%
Net Profit Margin
7.47%
EBITDA Margin
6.15%
EBIT Margin
-0.65%

Analyst Forecast

The average price target for Samjin Pharmaceutical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
0.28%
EPS Growth Forecast
16.80%

Scores

Smart Score
―
AI Score
62